Resting Imaging to Assess Cardiac Structure and Function: Recommendations Class I 1. Assessment of resting LV systolic and diastolic ven- tricular function and evaluation for abnormalities of myocardium, heart valves, or pericardium are rec- ommended with the use of Doppler echocardiogra- phy in patients with known or suspected IHD and a prior MI, pathological Q waves, symptoms or signs suggestive of heart failure, complex ventricular ar- Figure 8. Nomogram to predict risk of death based on clinical data and results of exercise testing. To determine risk, draw a vertical line from each risk marker to the top line, labeled POINTS, to calculate points for each risk marker. The sum of all these points is then marked on the line labeled TOTAL POINTS. Drop vertical lines from there to yield the 3- and 5-year sur- vival probabilities. For binary variables, 1 means yes and 0 means no. MET indi- cates metabolic equivalent. Reproduced from Lauer et al.248 Fihn et al Stable Ischemic Heart Disease: Full Text e381 rhythmias, or an undiagnosed heart mur- mur.21,57,58,260,261 (Level of Evidence: B) Class IIb 1. Assessment of cardiac structure and function with resting echocardiography may be considered in pa- tients with hypertension or diabetes mellitus and an abnormal ECG. (Level of Evidence: C) 2. Measurement of LV function with radionuclide im- aging may be considered in patients with a prior MI or pathological Q waves, provided there is no need to evaluate symptoms or signs suggestive of heart fail- ure, complex ventricular arrhythmias, or an undi- agnosed heart murmur. (Level of Evidence: C) Class III: No Benefit 1. Echocardiography, radionuclide imaging, CMR, and cardiac CT are not recommended for routine Figure 9. Euro heart score sheet to calculate risk score for patients presenting with stable angina (derived from 3779 patients with newly diagnosed SIHD). 